Search

Your search keyword '"Yablon SA"' showing total 98 results

Search Constraints

Start Over You searched for: Author "Yablon SA" Remove constraint Author: "Yablon SA"
98 results on '"Yablon SA"'

Search Results

2. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.

3. Comparison of indices of traumatic brain injury severity: Glasgow Coma Scale, length of coma and post-traumatic amnesia.

4. Prospective comparison of acute confusion severity with duration of post-traumatic amnesia in predicting employment outcome after traumatic brain injury.

5. Neuroanatomic basis of impaired self-awareness after traumatic brain injury: findings from early computed tomography.

6. Race and productivity outcome after traumatic brain injury: influence of confounding factors.

7. Conceptual dilemmas in evaluating individuals with severely impaired consciousness.

13. To the editors:.

15. Neurophysiologic evaluation of spastic hypertonia: implications for management of the patient with the intrathecal baclofen pump.

18. Delirium following traumatic brain injury in adolescents: Symptomatology and prediction of ability to return to school or employment 1-year post-injury.

19. Post-traumatic Confusional State: A Case Definition and Diagnostic Criteria.

20. Knee Muscle Stretch Reflex Responses After an Intrathecal Baclofen Bolus in Neurological Patients With Moderate-to-Severe Hypertonia.

21. Focal Electroencephalographic Changes Index Post-Traumatic Confusion and Outcome.

22. Intrathecal baclofen bolus reduces exaggerated extensor coactivation during pre-swing and early-swing of gait after acquired brain injury.

23. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology.

24. Effect of intrathecal baclofen bolus injection on ankle muscle activation during gait in patients with acquired brain injury.

25. Psychotic symptoms as manifestations of the posttraumatic confusional state: prevalence, risk factors, and association with outcome.

26. Do rehospitalization rates differ among injury severity levels in the NIDRR Traumatic Brain Injury Model Systems program?

27. Functional outcomes in traumatic disorders of consciousness: 5-year outcomes from the National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems.

28. Prospective evaluation of the nature, course, and impact of acute sleep abnormality after traumatic brain injury.

29. Electromyogram-lengthening velocity relation in plantar flexors during stance phase of gait in patients with hypertonia after acquired brain injury.

30. Effect of concentration and mode of intrathecal baclofen administration on soleus H-reflex in patients with muscle hypertonia.

31. Posttraumatic confusion predicts patient cooperation during traumatic brain injury rehabilitation.

32. Coactivation of ankle muscles during stance phase of gait in patients with lower limb hypertonia after acquired brain injury.

33. Longitudinal outcome of patients with disordered consciousness in the NIDRR TBI Model Systems Programs.

34. Utility of post-traumatic amnesia in predicting 1-year productivity following traumatic brain injury: comparison of the Russell and Mississippi PTA classification intervals.

35. Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.

36. Procedure- and device-related complications of intrathecal baclofen administration for management of adult muscle hypertonia: a review.

37. Prophylaxis for venous thromboembolism during rehabilitation for traumatic brain injury: a multicenter observational study.

38. Effect of intrathecal baclofen bolus injection on lower extremity joint range of motion during gait in patients with acquired brain injury.

39. Temporospatial characteristics of gait in patients with lower limb muscle hypertonia after traumatic brain injury.

40. Patterns of recovery of posttraumatic confusional state in neurorehabilitation admissions after traumatic brain injury.

42. Intrathecal baclofen therapy: an update.

43. Classification schema of posttraumatic amnesia duration-based injury severity relative to 1-year outcome: analysis of individuals with moderate and severe traumatic brain injury.

44. Serial yes/no reliability after traumatic brain injury: implications regarding the operational criteria for emergence from the minimally conscious state.

45. Effect of severity of post-traumatic confusion and its constituent symptoms on outcome after traumatic brain injury.

46. Therapeutic alliance in post-acute brain injury rehabilitation: predictors of strength of alliance and impact of alliance on outcome.

47. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.

48. Neurophysiological basis and clinical applications of the H-reflex as an adjunct for evaluating response to intrathecal baclofen for spasticity.

49. Deep venous thrombosis management following traumatic brain injury: a practice survey of the traumatic brain injury model systems.

50. Consensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spastic hypertonia.

Catalog

Books, media, physical & digital resources